NephrologyOnline.net

Nephrology Xagena

Search results for "Kidney disease"

The FDA ( Food and Drug Administration ) has approved Zemplar ( Paricalcitol ) capsules, an oral, activated vitamin D therapy for prevention and treatment of secondary hyperparathyroidism ( SHPT ). ...


Early treatment with drugs that block the renin-angiotensin system ( RAS ) may help prevent diabetes-related kidney disease, even before full-blown diabetes develops. Led by Yukiko Nagai of Kagawa ...


A study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions, found two common gene variations are associated with the risk for developing chronic kidney disea ...


A Mayo Clinic study found men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia ( BPH ) are three times more likely than other men to develop chr ...


Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades, and it appears the incidence of end-stage renal disease is lower than previo ...


Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, accord ...


The drug Rituximab causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study appearing in the November 2008 issue of th ...


The FDA ( Food and Drug Administration ) has advised healthcare professionals of significant liver injury associated with the use of Samsca ( Tolvaptan ). In a double-blind, 3-year, placebo-controlled ...


Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent ( ESA ), is a potential therapy for anemia in patients with advanced chronic kidney disease.Researchers have conducted two rand ...


Atherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized trials that did not show a benefit of renal-artery stenting with respect to kidney function, the useful ...


Results from the FIND-CKD study were presented at the American Society of Nephrology ( ASN ) Kidney Week in Atlanta, Georgia, USA. The FIND-CKD results have shown that Ferinject ( Ferric carboxymaltos ...


Combination therapy with angiotensin-converting–enzyme ( ACE ) inhibitors and angiotensin-receptor blockers ( ARBs, sartans ) decreases proteinuria; however, its safety and effect on the progression o ...


Tolvaptan ( Samsca ), a diuretic with a new mechanism of action, selectively binds to the vasopressin V2 receptor and inhibits reabsorption of water. Its effect on heart failure is proven, but its ben ...


Vasopressin V2-receptor antagonists may delay disease progression in autosomal dominant polycystic kidney disease ( ADPKD ). Trials with V2-receptor antagonists have been performed predominantly i ...


Tolvaptan ( Samsca ), a diuretic with a new mechanism of action, selectively binds to the vasopressin V2 receptor and inhibits reabsorption of water. Its effect on heart failure is proven, but its ben ...